Type in a keyword and see the report right away. Explore your online world!
If you have already a Newsmeter account:
You can free sign up for Newsmeter:
x
Regeneron has announced new results from the phase 2 COURAGE trial evaluating trevogrumab (anti-GDF8/anti-myostatin) for...
Pfizer has presented results from two phase 3 trials evaluating the efficacy and safety of...
The economic burden of chronic conditions is immense, encompassing healthcare expenditures, productivity losses and the...
Logistical challenges are not new in clinical research, from the high cost of developing new...
AbbVie has announced results from the ongoing phase 3 Viti-Up-1 and Viti-Up-2 studies of Rinvoq...
